Consistent with these studies, PAK1 protein levels are reduced by ~80% in the islets of humans with T2D, compared with non-diabetics, suggesting that deficiency of PAK1 or defects in PAK1 signaling may correlate to T2D susceptibility [98,99,101]. Here, PAK1 is linked to type 2 diabetes mellitus.